Thursday, May 15

Drug overdose deaths in the U.S. fell by 27% in 2024, marking the largest annual decline recorded.

Tuesday, Apr 22

Walgreens settles opioid prescription allegations for $300 million, agreeing to enhanced compliance measures and avoiding further litigation.

Thursday, Mar 20

Purdue Pharma files a new bankruptcy plan proposing a $7.4 billion settlement in response to opioid crisis lawsuits, aiming to benefit victims and communities.

Wednesday, Feb 05

Explore the complexities of the U.S. fentanyl crisis, including the China-Mexico trafficking pipeline, tariffs, and ineffective border control strategies.

Sunday, Feb 02

The FDA has approved Journavx, a new non-opioid pain medication, aiming to combat opioid addiction and overdose risks in patients.

Friday, Jan 31

The FDA has approved Journavx, a groundbreaking non-opioid painkiller, marking the first new class in over 20 years, aiming to eliminate the risks of opioid addiction.

Saturday, Jan 25

Purdue Pharma and the Sackler family reach a $7.4 billion settlement to resolve lawsuits related to the opioid crisis and OxyContin's toll in the U.S.

Friday, Jan 24

Purdue Pharma and the Sackler family agree to a $7.4 billion settlement to address ongoing lawsuits related to the opioid epidemic, marking a significant resolution in the crisis.

Saturday, Jan 18

The U.S. Justice Department has filed a lawsuit against Walgreens, accusing the pharmacy chain of filling millions of illegitimate opioid prescriptions.

Saturday, Jan 11

A former McKinsey partner pleads guilty to obstructing justice by destroying opioid-related records in a case tied to Purdue Pharma.